These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20121572)

  • 1. Does treatment with oseltamivir prevent transmission of influenza to household contacts?
    Hayward A
    Clin Infect Dis; 2010 Mar; 50(5):715-6. PubMed ID: 20121572
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus.
    Ng S; Cowling BJ; Fang VJ; Chan KH; Ip DK; Cheng CK; Uyeki TM; Houck PM; Malik Peiris JS; Leung GM
    Clin Infect Dis; 2010 Mar; 50(5):707-14. PubMed ID: 20121573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Oseltamivir Treatment With Virus Shedding, Illness, and Household Transmission of Influenza Viruses.
    Cheung DH; Tsang TK; Fang VJ; Xu J; Chan KH; Ip DK; Peiris JS; Leung GM; Cowling BJ
    J Infect Dis; 2015 Aug; 212(3):391-6. PubMed ID: 25646354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to neuraminidase inhibitors.
    Dolin R
    Clin Infect Dis; 2011 Feb; 52(4):438-9. PubMed ID: 21248366
    [No Abstract]   [Full Text] [Related]  

  • 5. Frequency of drug-resistant viruses and virus shedding in pediatric influenza patients treated with neuraminidase inhibitors.
    Tamura D; Sugaya N; Ozawa M; Takano R; Ichikawa M; Yamazaki M; Kawakami C; Shimizu H; Uehara R; Kiso M; Kawakami E; Mitamura K; Kawaoka Y
    Clin Infect Dis; 2011 Feb; 52(4):432-7. PubMed ID: 21248368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial.
    Welliver R; Monto AS; Carewicz O; Schatteman E; Hassman M; Hedrick J; Jackson HC; Huson L; Ward P; Oxford JS;
    JAMA; 2001 Feb; 285(6):748-54. PubMed ID: 11176912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials.
    Halloran ME; Hayden FG; Yang Y; Longini IM; Monto AS
    Am J Epidemiol; 2007 Jan; 165(2):212-21. PubMed ID: 17088311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors promoting the prolonged shedding of the pandemic (H1N1) 2009 influenza virus in patients treated with oseltamivir for 5 days.
    Ryoo SM; Kim WY; Sohn CH; Seo DW; Oh BJ; Lee JH; Lee YS; Lim KS
    Influenza Other Respir Viruses; 2013 Sep; 7(5):833-7. PubMed ID: 23279949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of neuraminidase inhibitors on household transmission in Japanese patients with influenza A and B infection: A prospective, observational study.
    Hirotsu N; Saisho Y; Hasegawa T
    Influenza Other Respir Viruses; 2019 Mar; 13(2):123-132. PubMed ID: 29989680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global transmission of oseltamivir-resistant influenza.
    Moscona A
    N Engl J Med; 2009 Mar; 360(10):953-6. PubMed ID: 19258250
    [No Abstract]   [Full Text] [Related]  

  • 11. The Timeline of Influenza Virus Shedding in Children and Adults in a Household Transmission Study of Influenza in Managua, Nicaragua.
    Ng S; Lopez R; Kuan G; Gresh L; Balmaseda A; Harris E; Gordon A
    Pediatr Infect Dis J; 2016 May; 35(5):583-6. PubMed ID: 26910589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of nasopharyngeal shedding of novel H1N1 (swine-like) influenza A virus in an immunocompetent adult under oseltamivir therapy.
    Charlier C; Enouf V; Lanternier F; Grandadam M; Amazzough K; Blanche S; Lecuit M; Lortholary O; van der Werf S
    Clin Microbiol Infect; 2009 Dec; 15(12):1189-91. PubMed ID: 19681951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009.
    Goldstein E; Cowling BJ; O'Hagan JJ; Danon L; Fang VJ; Hagy A; Miller JC; Reshef D; Robins J; Biedrzycki P; Lipsitch M
    BMC Infect Dis; 2010 Jul; 10():211. PubMed ID: 20642862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral treatment of patients with oseltamivir-resistant and oseltamivir-susceptible seasonal Influenza A (H1N1) infection during the 2007-2008 influenza season in the United States.
    Dharan NJ; Gubareva LV; Klimov AI; Fiore AE; Bresee JS; Fry AM
    Clin Infect Dis; 2010 Feb; 50(4):621-2. PubMed ID: 20095841
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of oseltamivir treatment of index patients with influenza on secondary household illness in an urban setting in Bangladesh: secondary analysis of a randomised, placebo-controlled trial.
    Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Trujillo A; Barnes J; Azim T; Bresee J; Luby SP; Brooks WA
    Lancet Infect Dis; 2015 Jun; 15(6):654-62. PubMed ID: 25788164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of viral shedding of influenza A (H1N1) virus infection treated with oseltamivir and/or traditional Chinese medicine in China: a retrospective analysis.
    Wang YG; Jiang M; Wang RB; Zha QL; Zhang SJ; Zhou GQ; Li XW; Wang YY; Lv AP
    J Tradit Chin Med; 2012 Jun; 32(2):148-55. PubMed ID: 22876436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.
    Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Azim T; Bresee J; Luby SP; Brooks WA
    Lancet Infect Dis; 2014 Feb; 14(2):109-18. PubMed ID: 24268590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of the neuraminidase inhibitor oseltamivir for the management of seasonal influenza].
    Ruf BR; Sandow P; Lehmann P; Del Piero L; Skopnik H
    Dtsch Med Wochenschr; 2008 Jun; 133(23):1259-64. PubMed ID: 18509804
    [No Abstract]   [Full Text] [Related]  

  • 19. Possible transmission of pandemic (HIN1) 2009 virus with oseltamivir resistance.
    Mandelboim M; Hindiyeh M; Meningher T; Mendelson E
    Emerg Infect Dis; 2010 May; 16(5):873-4. PubMed ID: 20409390
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiviral treatment and virological monitoring of oseltamivir-resistant influenza virus A(H1N1)pdm09 in a patient with chronic B lymphocytic leukemia.
    Salata C; Sgarabotto D; Del Vecchio C; Solimbergo E; Marini G; Nicolè S; Franchin E; Parolin C; Calistri A; Palù G
    J Infect Chemother; 2019 Jul; 25(7):543-546. PubMed ID: 31014561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.